2025-06-03-Jefferies-Aedifica_Cofinimmo（AED）_初步观点_合并协议_7页_108kb

报告摘要

Jefferies assigns a HOLD rating to Aedifica (AED BB) and Cofinimmo (COFB BB) based on their proposed merger.
The merger creates the largest European healthcare REIT with a Gross Asset Value (GAV) exceeding €12bn at an exchange ratio of 1.185 Aedifica shares per Cofinimmo share.
MANAGEMENT AGREEMENT: Boards of both companies unanimously support the combination, expected to be accretive at EPS level but neutral at NAV level.
TRANSACTION STRUCTURE: All-share offer with 50%+1 acceptance threshold, proposed EGM on July 11, 2025, and offer likely opening in September 2025.

PRICE AND TERMS: New exchange ratio of 1.185 vs previous 1.16; target prices at €68.00 for AED and €80.00 for COFB, up from current levels.
SYNERGIES: Estimated €16m savings to harmonize cost ratios, unchanged from prior expectations.
POST-COMBINATION: AED's board will include independent directors from both firms; Cofinimmo's chairman becomes chairman of Aedifica.

Aedifica: Target price via blended DCF, DDM, and Adjusted NAV; risks include higher CPI leading to LT rate increases and credit downgrade.
Cofinimmo: Similar valuation; additional risks include operator bankruptcies in healthcare and yield expansion.
Rating: HOLD for both, with price targets reflecting current analysis.

STRONG INVESTOR SUPPORT: Deal likely proceeds due to recent positive discussions and overlap in shareholder bases.
OTHER POINTS: Companies focus on healthcare real estate, with AEdifica in elderly care and COfinimmo diversified ( healthcare 77%, office 15%, distribution 8%).

展开完整摘要